Copyright
©The Author(s) 2025.
World J Stem Cells. Jul 26, 2025; 17(7): 105371
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.105371
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.105371
Table 2 Antioxidant and anti-inflammatory mechanisms of acupuncture
Ref. | Model | Intervention | Acupoints | Acupoint stimulation parameters | Mechanism indicators | Pathway |
Zhang et al[86] | IBD mice | EA | Bilateral: BL25 | EA: 2 Hz, 1 mA, 30 minutes, 7 days | IL-1β↓; iNOS↓; CD68↓ | - |
Song et al[90] | UC mice | EA | ST36 | EA1: 100 Hz, 1 mA, 30 minutes, 7 days; EA2: 10 Hz, 1 mA, 30 minutes, 7 days | IL-1β↓; IL-6↓; IL-12↓; TNF-α↓; IL-17↓; IL-10↑ | - |
Zhou et al[95] | PTSD mice | EA | Pretreatment | EA: 2/15 Hz, 1 mA, 30 minutes, 7 days | BDNF↓; AMPK↓; HO-1↓ | AMPK/Nrf2; Keap1/Nrf2 |
Yu et al[96] | ALI rabbits | EA | Bilateral: ST36; BL13 | EA1: 2/15 Hz, ≤ 1 mA, 15 minutes, 5 days; EA2: 2/15 Hz, ≤ 1 mA, 6 hours, 1 days | MDA↓; SOD↑; GPX↑; TNF-α↓; IL-6↓; HO-1↑ | Nrf2/ARE |
Dai et al[153] | SCI mice | EA | Bilateral: ST36; SP6 | EA: 60 Hz for 1.05 seconds and 2 Hz for 2.85 seconds, alternately; ≤ 5 μA | ApoE↑; TNF-α↓; IL-6↓; IL-1β↓; IL-10↑; TGF-β↑ | Nrf2-HO-1; Nrf2/NQO1/HO-1 |
Li et al[154] | CIRI rats | EA | GV20, SP6, bilateral: ST36 | EA: 2/15 Hz, 5 mA or 10 mA, 30 minutes, 5 days | TNF-α↓; HO-1↑; iNOS↓ | Nrf2/HO-1 |
Wang et al[155] | VD mice | Acupuncture | GV20, bilateral: ST36 | 10 minutes needle retention | TNF-α↓; TLR4↓; IL-6↓ | MyD88/NF-κB |
Lou et al[156] | I/R rats | EA | Pretreatment: ST36; SP6 | EA: 2/15 Hz, 1 mA | TNF-α↓; IL-1↓; IL-6↓; MPO↓; TLR4↓; p-NF-κB↓ | TLR4/NF-κB |
Wu et al[157] | UC rats | EA and HPM | EA: Bilateral ST25. HPM: (Qihai)RN6; bilateral (Tianshu)ST25 | EA: 2 Hz, 4 mA, 20 minutes, 14 days; HPM: Moxa cones (refined mugwort floss) | IL-1β↓; IL-6↓ | - |
Liu et al[158] | UC mice | EA | Bilateral: ST36 | EA: 2 Hz, 1 mA, 15 minutes, 7 days | IFN-γ↓; IL-6↓; TNF-α↓ | TLR4/MyD88 |
- Citation: Ma WG, Si YX, Zhang YL, Gao WF, Dong YG, Li YQ, Xu ZF, Xi Q, Li ZZ. Combining acupuncture and mesenchymal stem cell therapy offers promise as a treatment for inflammatory bowel disease. World J Stem Cells 2025; 17(7): 105371
- URL: https://www.wjgnet.com/1948-0210/full/v17/i7/105371.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i7.105371